Metaverse: Is The Future Real? – Panel Presentation from NobleCon18

5/2/2022

Tech

0 min read

Metaverse: Is The Future Real?

The Metaverse has the potential to disrupt a large number of industries. What’s in store for the next gen of the Internet? How should businesses prepare?

Moderator: Eric Bolling, TV Personality and Host of Eric Bolling The Balance
Rob Goldman, Head of Growth & Monetization, Facebook (former)
Mike Federle, CEO, Forbes Media Group
Christopher Ruddy, CEO, Newsmax
Dimitry Kozko, CEO, Motorsport Games

NobleCon 18 Complete Rebroadcast

Take it to the next level. It doesn’t cost a penny.

Join the Channelchek Investor Community. Your name, email, zip, and investor type is all it takes to open the door to research reports, favorites tracking, and virtual and in-person roadshows / conferences. Even exclusive investment opps.

‌

The site "channelcheck" is opened on the phone

Welcome to the Channelchek Investor Community

We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.

Don't have an account? Join

Forgot password

By clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.

Release – FAT Brands Inc. Announces Second Quarter Cash Dividend on Class A Common Stock and Class B Common Stock

FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT), a leading global franchising company and parent company of iconic brands including Round Table Pizza, Fatburger, Marble Slab Creamery, Johnny Rockets, Twin...

3 min read

‌

Release – MAIA Biotechnology Announces $1.00 Million Private Placement

4/23/2024

Health

Release – MAIA Biotechnology Announces $1.00 Million Private Placement

MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase...

5 min read

‌

Release – PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer

4/23/2024

Health

Release – PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer

PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious...

7 min read

‌

Release – V2X to Announce First Quarter 2024 Financial Results

4/23/2024

Defense

Release – V2X to Announce First Quarter 2024 Financial Results

V2X, Inc., (NYSE: VVX), a leading provider of global mission solutions, will report first quarter 2024 financial results on Tuesday, May 7, 2024, before market open. Senior management will conduct...

2 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

NewsMorning ResearchVideos

By clicking submit you are agreeing to the Terms of Use and Privacy Policy